GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
- A study conducted at a Dublin clinic found that overweight patients prescribed semaglutide or liraglutide decreased their alcohol intake by approximately 68% over a period of four months.
- This study tracked 262 clinically overweight or obese patients, 68% of whom drank regularly, to explore GLP-1 drugs' effects beyond weight loss.
- On May 9, 2025, researchers shared these results at a conference focused on obesity research held in Malaga, Spain, and highlighted the study's limitations, including a small sample size and the absence of a control group.
- Dr. Carel le Roux, a senior researcher at University College Dublin, noted that patients described reducing their alcohol consumption as nearly effortless, and indicated that GLP-1 analogues could potentially decrease cravings for both food and alcohol.
- These results indicate GLP-1 drugs could aid alcohol reduction, which is significant since alcohol causes nearly 5% of deaths worldwide, but further research is needed to confirm this effect.
Insights by Ground AI
Does this summary seem wrong?
44 Articles
44 Articles
All
Left
5
Center
13
Right
8

+24 Reposted by 24 other sources
GLP-1 Weight Loss Drugs Cut Alcohol Cravings By Two-Thirds
Key Takeaways
·Cherokee County, United States
Read Full ArticleCoverage Details
Total News Sources44
Leaning Left5Leaning Right8Center13Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 19%
C 50%
R 31%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage